On April 6 2026, the Centers for Medicare & Medicaid Services finalized a 2.48% increase in Medicare Advantage payment rates for 2027, a decision that adds more than $13 billion in additional payments to plans nationwide. The higher rates directly benefit Humana’s Medicare Advantage business, raising per‑member revenue and improving the company’s margin outlook.
The payment increase comes at a time when Humana is working to offset a 2026 Star Ratings headwind that has reduced bonus payments. By boosting Medicare Advantage reimbursement, the new rates help neutralize the impact of lower quality scores and provide a tailwind for the insurer’s earnings. The adjustment also supports Humana’s focus on sustainable growth and cost control.
Humana’s recent financial performance provides context for the significance of the payment change. In Q1 2025, the company reported revenue of $30.937 billion and adjusted earnings per share of $11.58, compared with $29.6 billion in revenue and $741 million net income in Q1 2024. The company has reaffirmed its full‑year 2025 adjusted EPS guidance of approximately $16.25, while revising its GAAP EPS guidance.
Analysts had expected a 1–2% increase in Medicare Advantage rates, so the 2.48% final figure exceeded market expectations. The higher‑than‑anticipated increase was a key driver of the positive market reaction, as investors recognized the substantial revenue boost for insurers.
Investors responded positively to the announcement, with the market reaction driven by the magnitude of the increase and its implications for Humana’s earnings. The reaction reflected confidence that the payment adjustment will strengthen the company’s financial position.
Management and regulators highlighted the benefits of the new rates. Humana President and CEO Jim Rechtin said, "Our team has done a great job launching us on a strong start to the year. Medicare Advantage is performing as expected and we are excited about our progress in expanding CenterWell and Medicaid." He added, "We are confident in the growth outlook for value‑based care and Medicare Advantage, which will allow us to provide more quality care to a broader group of patients and members." CMS Administrator Dr. Mehmet Oz noted, "Medicare Advantage and Part D should work for the people who rely on them. These updates keep coverage affordable and ensure patients get real value from their plans." Chris Klomp, Director of Medicare and Chief Counselor of the U.S. Department of Health and Human Services, said, "CMS' vision for Medicare Advantage and Part D is clear: a great choice for seniors and a smart deal for taxpayers. The Rate Announcement improves payment accuracy and strengthens competition based on quality—not on coding practices—helping put the program on a more sustainable path for the long term."
The payment increase provides a significant tailwind for Humana, offsetting Star Ratings headwinds and reinforcing confidence in the company’s value‑based care strategy. The adjustment is expected to support margin expansion and sustain the insurer’s growth trajectory in the Medicare Advantage market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.